CVS Q4 results beat Wall Street expectations, boosted by pharmacy benefits business

CVS Health exceeded Wall Street's expectations with its 2019 fourth-quarter results, released Feb. 12, boosted largely by its pharmacy benefit management business. 

The retail pharmacy giant reported revenues of $66.9 billion, up from the expected $63.97 billion. 

CVS's health benefits business more than doubled its revenue from $6.24 billion in the last quarter of 2018 to $17.5 billion for the 2019 fourth quarter. The results are likely due to the company acquiring Aetna in November 2018.

Its pharmacy unit also went up 4.1 percent, with $37 billion in revenue in the fourth quarter, compared to $34 billion the year before.

Thanks to the better-than-expected results, the company raised its outlook for 2020, saying it now expects 2020 earnings between $7.04 per share and $7.17 per share. 

Read the full report here

More articles on pharmacy:
Ascension VP on shifting priorities for hospital pharmacies, next generation of pharmacists
McKesson could lose wholesale license over 'excessive' opioid orders to children's hospital
CMS ready to survey 340B hospitals about how they use program savings

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.